Equities

National Research Corp

National Research Corp

Actions
Health CareHealth Care Providers
  • Price (USD)19.73
  • Today's Change0.605 / 3.16%
  • Shares traded20.40k
  • 1 Year change-52.52%
  • Beta0.5160
Data delayed at least 15 minutes, as of Nov 25 2024 16:49 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments6.652554
Total Receivables, Net131515
Total Inventory------
Prepaid expenses4.232.393.88
Other current assets, total0.861.010.88
Total current assets244474
Property, plant & equipment, net301813
Goodwill, net626262
Intangibles, net1.471.611.79
Long term investments------
Note receivable - long term------
Other long term assets3.273.263.28
Total assets122130158
LIABILITIES
Accounts payable1.301.151.94
Accrued expenses9.439.0613
Notes payable/short-term debt000
Current portion long-term debt/capital leases7.244.804.75
Other current liabilities, total181821
Total current liabilities363340
Total long term debt291823
Total debt372327
Deferred income tax4.145.277.00
Minority interest------
Other liabilities, total3.652.012.20
Total liabilities735872
SHAREHOLDERS EQUITY
Common stock0.030.030.03
Additional paid-in capital178175174
Retained earnings (accumulated deficit)(31)(25)(36)
Treasury stock - common(99)(78)(50)
Unrealized gain (loss)------
Other equity, total----(2.38)
Total equity497285
Total liabilities & shareholders' equity122130158
Total common shares outstanding242525
Treasury shares - common primary issue6.786.295.54
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.